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Although the identity of the chemical mediator of renal hypertension has
not as yet been established, the development of a method for the production
of persistent arterial hypertension (2) has stimulated studies which may lead
to its identification  and isolation.  Meanwhile,  the availability of the hy-
pertensive  animal  has  opened  an  avenue  of  study  of  the  nature  of  the
mediator by indirect means, chiefly by the investigation of its physiological
properties.  In the past few years we have utilized the Goldblatt method to
study some of the properties of this mediator.  In the present communica-
tion we report further studies  along this line.  No attempt will be made to
analyze the literature critically,  but we consider it important to recapitulate
some  conclusions  from  our previous  studies.
While  renal excretory  insufficiency  and  hypertension  are frequently  associated,  the
mechanisms responsible for them are independent  (3).  Renal hypertension is apparently
not the result  of a diminished production of a  depressor substance by  the kidney  since
no persistent change in arterial pressure follows total nephrectomy  in the normotensive
animal (4).  The absence of any persistent further rise in blood pressure in hypertensive
dogs  after total  nephrectomy  (4)  makes unlikely  the possibility  that a depressor  sub-
stance  is manufactured  by the  normal kidney in  the presence  of  hypertension.
Within  a period  of one year,  the  chemical  mediator of renal hypertension  does  not
lead  to permanent  changes  which  tend  to perpetuate  the  hypertension,  since  removal
of ischemic  kidney  tissue  within  this  time  leads  to  a return  of the  blood  pressure  to
normotensive  levels  (4).  It  is probably  not a sympathetico-mimetic  substance  since
its action  is unaffected  by  the  dioxane  derivative  933 F which  reverses  the action  of
epinephrine  (5).  The  mediator  has  no  demonstrable  vasoconstrictor  effect  upon  the
arterioles  in  the pulmonary circuit  since  the  arterial  pressure  in  the  lesser  circuit is
not elevated in  marked  systemic  arterial  hypertension  (6).  Moreover,  since  normo-
tension persists after total  nephrectomy,  whether the animal  be  normotensive  or hy-
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pertensive  before  the  nephrectomy  (4),  it is unlikely  that  the  mediator  is a factor  in
the maintenance of normal  blood  pressure.
Renal hypertension appears to be a function of the ratio of ischemic to normal kidney
tissue, the  normal  kidney tissue  being  implicated in  the elimination  or  neutralization
of  the  mediator.  Thus,  removal  of  the  non-ischemic  kidney  in  dogs  with  unilateral
renal  ischemia  leads to an intensification  of the hypertension,  or  to its appearance  for
the first time  (7).  Further, in dogs with hypertension due to unilateral renal  ischemia,
removal of the ischemic kidney results in a return of the blood pressure to normotensive
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FIG. 1.  The rate of dissipation  of hypertension  following removal of the ischemic kid-
ney in seven dogs with the remaining kidney normal  (curve A)  and in six dogs with no
remaining kidney (curve B).  Abscissa gives time in hours.  Zero time is the time during
the operation when the blood supply to the  kidney to be removed is occluded.  Ordinates
show the average diastolic pressure readings in mm. Hg in each series.  N is the diastolic
pressure  level which  existed  before  renal hypertension  developed.  These  curves  sum-
marize  results  of  a  previous  communication  (4).
levels within 6 hours if a normal  kidney remains in the body; but if no normal kidney is
present, the blood pressure  falls more slowly  and reaches the normotensive level in about
25  hours  (4, 8)  (Fig.  1).
These observations  raised the question of whether the elimination of the
chemical  mediator  is  accomplished  by  the  excretory  function  or  by  the
metabolic  process  of  the  normal  kidney.  The present  study was  under-
taken to distinguish between these two closely associated functions in order
to determine which mechanism  is involved in neutralizing  the hypertensive
effect  of  the  ischemic  kidney.  During the  course  of  the  study,  observa-
tions  were  also  made  upon  the  effect  of  the  metabolic  activity  of  the
kidney  on the  development  of the uremic  syndrome.
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Methods
The r6le  of  renal excretory  activity in hypertension  was investigated  in
dogs with unilateral renal ischemia by permitting the urine excreted by the
normal kidney  to  return  to  the blood  stream  via a  uretero-venousfistula.
Utilization  of this procedure permits  the metabolic and excretory activities
of the kidney to continue presumably unchanged while the excreted products
are  returned  to the  blood  stream.  Should  the  mediator  be  excreted  into
the  urine, it would  automatically  be returned  to the blood  and its pressor
activity  should  not be  lessened.
The role  of  the metabolic  activity of the normal kidney in hypertension
was  investigated  in  such  dogs  with  unilateral  renal  ischemia  and  contra-
lateral uretero-venous  fistula by determining  the time for dissipation of the
hypertension after removal of the ischemic kidney.  If the kidney process
neutralizing  hypertension  is metabolic,  it would  be expected that the rate
of dissipation of the hypertension  following  removal of the ischemic kidney
would be as rapid as when a normal kidney without such a fistula remained.
If the renal process neutralizing hypertension is of an excretory nature, then
the rate of dissipation  of the hypertension  would  be  as slow  as that which
occurs  in  the  totally  nephrectomized  animal.  The  experiment  was  con-
trolled by a similar procedure in normotensive  dogs with unilateral uretero-
venous fistulae.
All blood pressure  determinations  were made  with  the Hamilton  needle manometer
technique  (9) upon  trained  unanesthetized  dogs  according  to the  method previously
described  by  us  (10).  The  period  of  training  was  considered  completed  when  the
diastolic blood pressure on at least three successive readings  was  found to be constant
within  -15  mm.  Hg.
All operations on these  animals were  done aseptically under nembutal or ether anes-
thesia.  Ether was used  whenever  the total renal excretory  processes  were eliminated,
in  order to insure adequate  excretion of the anesthetic.  Unilateral  renal ischemia  was
produced in some of these trained  animals  by means of  Goldblatt clamps  (2) or linen
ligatures used in  a manner similar  to the method of Drury (11).  Some days after the
development of hypertension,  the ureter of the non-ischemic kidney was  cannulated to
the central  end of a lumbar vein or directly  into the inferior vena cava.  A small glass
cannula was  employed  for  this purpose  and its patency  was  checked  at necropsy,  by
determining whether the injection of India ink into the pelvis of the kidney led to the
presence  of the  pigment  in  the  inferior vena  cava.  At  necropsy a mild  to moderate
hydronephrosis  of the  kidney  with  the  uretero-venous  fistula was  consistently  found.
Whenever the anastomosis  was broken, a leak occurred and a urinary fistula developed
along  the  line  of incision;  the data  on these  experiments  were  discarded.
The course of the blood pressure  was followed for a variable number of days before
the next stage was pursued.  After this period of observation,  the ischemic kidney was
removed, leaving the non-ischemic kidney with its uretero-venous fistula in situ.  Hourly
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blood pressure determinations  were made  to discover  the point at which the normoten-
sive level was reached.  As in our previous studies (4), the end point of the hypertensive
level was selected as the time at which the diastolic pressure first reached within  5 mm.
Hg of its normal control level;  zero  time was considered  to be the  time of occlusion  of
the blood supply  of the kidney to be removed.  Estimates were  made  of the rate and
intensity  of  the  development  of  uremia  as  indicated  by  the  development  of apathy,
gastrointestinal  irritation  (vomiting and  diarrhea),  and  increased  nervous  irritability
(twitching  and  tremors)  and  terminal  narcosis.  The blood  non-protein  nitrogen  was
also  determined  from  time  to time.
Similar procedures were carried out on the control animals, the details being identical,
with  the  exception  that  unilateral  renal  ischemia  was  not  produced.
RESULTS
1.  The  Immediate  Effect  of  Contralateral Nephrectomy  on  Blood  Pres-
sure in Dogs with Unilateral Uretero-Venous Fistulae.-Experiments  were
carried  out successfully  on seven  dogs  with hypertension  caused  by uni-
lateral renal ischemia.  A uretero-venous fistula of the contralateral normal
kidney was established  12,  15,  5,  35,  49,  10,  and 27  days respectively after
the  induction  of  the  unilateral renal  ischemia.  The  ischemic  kidney was
removed  in  these  animals  7, 1, 5,  2, 0,  2,  and  1 days  respectively  after
establishing the uretero-venous  fistula.  In the first of these animals uremia
was well  developed at the time of the nephrectomy,  the blood non-protein
nitrogen being 264 mg. per cent at this time.  The lag in the disappearance
of  the  hypertension  following  nephrectomy  in  these  animals  is  shown  in
summary fashion  in Fig. 3 and a typical experiment  is presented in Fig.  2.
It was found that the hypertension  was dissipated in 1, 6,  2,  7, 4, 6,  and
5½  hours  respectively  following  removal  of  the ischemic  kidney,  or on the
average  within 4  hours.
In control experiments  four  normotensive  dogs with unilateral  uretero-
venous  fistulae  were  used,  in  which  contralateral  nephrectomy  was  per-
formed 1, 2, 5, and 29 days respectively after establishing  the fistula.  Fol-
lowing  nephrectomy  a  transient  rise  of  diastolic  pressure,  15  mm.  Hg,
occurred in one, returning to the control value in 4 hours.  In the other three
dogs  no such immediate  change  in  blood pressure  occurred.
It  is apparent that in dogs with a uretero-venous  fistula in situ the time
for  dissipation  of  the  hypertension  following  the removal  of  the ischemic
kidney was of  the same order as in these  cases  in which  a normal kidney,
excreting into  the urinary  bladder,  remained  (4)  (compare  Figs.  1 and 3).
Actually, the maximum time for the dissipation was somewhat  less than in
the previous experiments referred to.  This may be due to an improvement
in  our technique  of  nephrectomy  whereby  damage  to the  perirenal  nerve
plexuses  was  minimized  with  a  consequent  reduction  in  intensity  of  the
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post-nephrectomy  "neurogenic" blood pressure rise.  This is suggested  by
the fact  that in only  one  of  the four  control  animals  did a "neurogenic"
rise occur  and then it was small in amount.
We have therefore demonstrated that the rapid elimination of the pressor
activity of the mediator continues even  after the excretory function  of the
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FIG.  2.  The  rate of  dissipation  of hypertension  in  a  dog  with  unilateral  uretero-
venous  fistula,  following removal of  the contralateral  ischemic kidney.  The chart also
shows  the  control  blood pressure  and  blood  non-protein  nitrogen,  and  the  effect  on
these  two variables  of unilateral  renal ischemia  and subsequent  contralateral  uretero-
venous  fistula.  The  effect  of  the  removal  of  the  ischemic  kidney  is  enclosed  in  the
frame; the time scale in this frame is in hours instead of days as in the earlier part of the
figure.  Zero time in the frame is the time during the operation when the blood supply
to  the right kidney  was  completely  occluded.
kidney is effectively  removed by the uretero-venous  fistula.  This indicates
clearly  that the hypertension-neutralizing  action  of  the  normal kidney  is
due  to  its metabolic  activity.
The  above  results  further  strengthen  and amplify  the  thesis  that the
presence  and persistence  of hypertension  is  a function  of the ratio:
amount  of ischemic  kidney tissue
amount of normal kidney tissue  '
Our experiments  do  not preclude  the  possibility  that the  mediator  of
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hypertension  is also destroyed by the ischemic kidney.  However,  since the
ischemic kidney appears to be the source of the mediator,  any such destruc-
tion  must  be exceeded  by  its  production.  Clinically,  kidneys  with  both
ischemic  and non-ischemic  portions may occur  and  result in no  change  in
blood  pressure.  As  yet,  however,  we  have  no  satisfactory  experimental
method  for  demonstrating  both normal  and  ischemic  tissue  in  the  same
kidney.
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FIG.  3.  The rate of dissipation of hypertension in seven dogs with unilateral uretero-
venous  fistulae  following  removal  of the  contralateral  ischemic kidney.  Conventions
as in  Fig.  1.  The  top and bottom curves  give the  range and the middle  curve shows
the average  of the blood pressure  readings.
The  middle  curve  in  this  figure  was  obtained by  averaging  the  pressures  at  each
time interval.  The  average time  for the dissipation  of hypertension  computed in this
way is longer than that obtained in the text.  The latter is the average time for the re-
turn to the  normal level  in the seven  experiments.
In  indicating  that the  chemical  mediator  of  renal  hypertension  is  pro-
duced primarily by the ischemic  kidney and metabolized  to a non-pressor
state  by the normal  kidney,  our  experiments  lead  us to  suggest  that the
kidney  normally  is  able  to manufacture  as  well as  destroy the  mediator.
It would be peculiar indeed, if this ability to destroy the mediator developed
in the non-ischemic  kidney only after the mediator was formed in  ischemic
kidney tissue.  It  is more in accord  with known biological  mechanisms to
assume that in normal kidney both processes go on at about the same rate.
This suggests the hypothesis that the mediator is a normal product of renal
intermediate metabolism  and is usually destroyed before it can accumulate
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in the blood sufficiently  to cause a blood pressure rise.  Whenever abnormal
conditions  such  as  ischemia  arise,  the reaction  is blocked  at  the  stage  in
which  the intermediate  products are  pressor in nature  and  these can then
pass  into  the  blood  stream.  However,  the  presence  of  a  normal  kidney
enables  this  pressor  product  of renal intermediate  metabolism  to be  con-
verted to  non-pressor  forms,  thereby more  or less  effectively  neutralizing
the  tendency  to hypertension.
2.  The Development of Uremic Symptoms and the Blood Non-Protein  Nitro-
gen Changes Following a Uretero-Venous Fistula.-A total of fifteen unilat-
eral uretero-venous  fistulae were made.  Neither uremic nor "nephrotoxic"
symptoms developed and no rise in blood non-protein nitrogen  occurred as
long as the opposite kidney remained.  This was true when the other kidney
was normal, or when its renal artery was  constricted,  even to the point of
causing hypertension.'
This confirms and extends the recent findings of Geer and Dragstedt  (12).
It  is contrary to the reports of several investigators  (13-18)  who found  that
a unilateral uretero-venous  fistula led to symptoms like uremia which  they
attributed to  a postulated  "nephrotoxin."
When  the  contralateral  kidney  was  removed  leaving  only  the  kidney
with  the  uretero-venous  fistula  in situ, a  progressive  rise  in  blood  non-
protein nitrogen  was  observed  in  all eleven  of  the animals.  The  rate  of
this non-protein nitrogen rise was 30 to 60 mg. per cent per day.  All these
animals  developed uremic  symptoms and died of uremia in much the same
fashion  as totally nephrectomized  dogs.  A similar effect was noted in two
other  dogs  when  a  uretero-venous  fistula  of  the  remaining  kidney  was
established  6  and  14  days  respectively after uninephrectomy.
Our observations  that dogs with uretero-venous  fistulae in the remaining
kidney developed uremia at a rate and intensity roughly equal to that which
follows  bilateral  nephrectomy  indicate that the metabolic  activities of the
kidney play little or no rle in neutralizing the products  responsible for the
uremic syndrome.  Thus if specific  substances give rise to the uremic  syn-
drome,  they must  be  different  from  those  involved  in  the  production  of
renal hypertension.  The former would be removed  by the excretory activ-
ity of  the  kidney  and  would  accumulate  whenever  this  renal  function  is
impaired,  whereas the latter are removed  by the metabolic  activity of the
normal kidney.
It is noteworthy that while the hypertension was dissipated after removal
of  the ischemic kidney within  a few hours when the remaining kidney had
'The  blood  pressure  changes occurring  at  the  same  time  are  discussed  in another
communication  (19).
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a  uretero-venous  fistula,  the  renal  excretory  insufficiency  was  simultane-
ously  heightened  (Fig.  2).  This  is  further  evidence  for  the  dissociation
existing between the mechanisms involved in the production of renal hyper-
tension and  of uremia  (3).
SUMMARY
1. The  chemical mediator  of renal hypertension  is rapidly  destroyed by
the metabolic  activity  of the normal  kidney.  The  excretory  function  of
the  kidney  plays  little,  if  any,  r61le  in  eliminating  the  mediator  of
hypertension.
2.  If  specific  substances  are  responsible  for  the  uremic  syndrome,  they
are neither produced nor eliminated  to any significant extent  by the meta-
bolic  activity of  the kidneys.  The elimination of these postulated uremia-
producing substances  would  have  to  be primarily  dependent upon  the ex-
cretory  activities of  the kidney.
3.  No evidence was obtained to support the view that a unilateral uretero-
venous  fistula  leads  to "nephrotoxic"  symptoms.
We  are indebted  to  Dr.  M.  Sokolow  and Miss L.  Friedberg  for  their valuable  as-
sistance.
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